相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Direct cardiac effects of SGLT2 inhibitors
Sha Chen et al.
CARDIOVASCULAR DIABETOLOGY (2022)
Impaired muscle mitochondrial energetics is associated with uremic metabolite accumulation in chronic kidney disease
Trace Thome et al.
JCI INSIGHT (2021)
With a grain of salt: Sodium elevation and metabolic remodelling in heart failure
Dunja Aksentijevic et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2021)
Cardiovascular Disease in Chronic Kidney Disease Pathophysiological Insights and Therapeutic Options
Joachim Jankowski et al.
CIRCULATION (2021)
SGLT2 Inhibitors and Kidney and Cardiac Outcomes According to Estimated GFR and Albuminuria Levels: A Meta-analysis of Randomized Controlled Trials
Kwang Jin Chun et al.
KIDNEY MEDICINE (2021)
Uraemic Cardiomyopathy: A Review of Current Literature
Kartheek Garikapati et al.
CLINICAL MEDICINE INSIGHTS-CARDIOLOGY (2021)
Endogenous cardiotonic steroids and cardiovascular disease, where to next?
Davor Pavlovic
CELL CALCIUM (2020)
The Redox-Sensitive Na/K-ATPase Signaling in Uremic Cardiomyopathy
Jiang Liu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
Boris Bikbov et al.
LANCET (2020)
IRF1-mediated downregulation of PGC1α contributes to cardiorenal syndrome type 4
Yinghui Huang et al.
NATURE COMMUNICATIONS (2020)
Intracellular sodium elevation reprograms cardiac metabolism
Dunja Aksentijevic et al.
NATURE COMMUNICATIONS (2020)
Prevalence of chronic kidney disease in adults in England: comparison of nationally representative cross-sectional surveys from 2003 to 2016
Hilda O. Hounkpatin et al.
BMJ OPEN (2020)
Mitochondrial Dysfunction in Kidney Disease and Uremic Sarcopenia
Koji Takemura et al.
FRONTIERS IN PHYSIOLOGY (2020)
Empagliflozin Decreases Lactate Generation in an NHE-1 Dependent Fashion and Increases α-Ketoglutarate Synthesis From Palmitate in Type II Diabetic Mouse Hearts
Hong Zhang et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Comprehensive quantification of fuel use by the failing and nonfailing human heart
Danielle Murashige et al.
SCIENCE (2020)
Empagliflozin enhances human and murine cardiomyocyte glucose uptake by increased expression of GLUT1
Julian Mustroph et al.
DIABETOLOGIA (2019)
Chronic Kidney Disease and Dietary Measures to Improve Outcomes
Oleh M. Akchurin
PEDIATRIC CLINICS OF NORTH AMERICA (2019)
Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study
Sarah J. Schrauben et al.
BMC NEPHROLOGY (2019)
A randomized controlled trial of the effect of spironolactone on left ventricular mass in hemodialysis patients
Fabian Hammer et al.
KIDNEY INTERNATIONAL (2019)
Mitochondria as a Source and a Target for Uremic Toxins
Vasily A. Popkov et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Andrew A. House et al.
KIDNEY INTERNATIONAL (2019)
Glucose Metabolism in Cardiac Hypertrophy and Heart Failure
Diem H. Tran et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2019)
Chronic Kidney Disease Diagnosis and Management: A Review
Teresa K. Chen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Chronic Kidney Disease as a Risk Factor for Heart Failure With Preserved Ejection Fraction: A Focus on Microcirculatory Factors and Therapeutic Targets
Jens van de Wouw et al.
FRONTIERS IN PHYSIOLOGY (2019)
Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial
David M. Charytan et al.
KIDNEY INTERNATIONAL (2019)
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
Thomas A. Zelniker et al.
LANCET (2019)
Evolving concepts in the pathogenesis of uraemic cardiomyopathy
Xiaoliang Wang et al.
NATURE REVIEWS NEPHROLOGY (2019)
Enhanced Redox State and Efficiency of Glucose Oxidation With miR Based Suppression of Maladaptive NADPH-Dependent Malic Enzyme 1 Expression in Hypertrophied Hearts
Ryan Lahey et al.
CIRCULATION RESEARCH (2018)
The Unexpected Effects of L-Carnitine Supplementation on Lipid Metabolism in Hemodialysis Patients
Lea Katalinic et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2018)
NAD(H) in mitochondrial energy transduction: implications for health and disease
Matthew A. Walker et al.
CURRENT OPINION IN PHYSIOLOGY (2018)
The role of cardiac energy metabolism in cardiac hypertrophy and failure
Tomi Tuomainen et al.
EXPERIMENTAL CELL RESEARCH (2017)
Sodium potassium adenosine triphosphatase (Na/K-ATPase) as a therapeutic target for uremic cardiomyopathy
Xiaoliang Wang et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2017)
Heart Failure with Preserved and Reduced Ejection Fraction in Hemodialysis Patients: Prevalence, Disease Prediction and Prognosis
Marlies Antlanger et al.
KIDNEY & BLOOD PRESSURE RESEARCH (2017)
Imaging of Myocardial Fibrosis in Patients with End-Stage Renal Disease: Current Limitations and Future Possibilities
M. P. M. Graham-Brown et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Indoxyl Sulfate: A Novel Cardiovascular Risk Factor in Chronic Kidney Disease
Szu-Chun Hung et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
Metabolic remodeling in hypertrophied and failing myocardium: a review
Mark A. Peterzan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
Normalization of NAD+ Redox Balance as a Therapy for Heart Failure
Chi Fung Lee et al.
CIRCULATION (2016)
The role of fibroblast growth factor 23 and Klotho in uremic cardiomyopathy
Alexander Grabner et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2016)
Echocardiography Criteria for Structural Heart Disease in Patients With End-Stage Renal Disease Initiating Hemodialysis
LaTonya J. Hickson et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Glucose Transporters in Cardiac Metabolism and Hypertrophy
Dan Shao et al.
COMPREHENSIVE PHYSIOLOGY (2016)
Insulin resistance in chronic kidney disease: a systematic review
Belinda Spoto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Elevated Plasma Marinobufagenin, An Endogenous Cardiotonic Steroid, Is Associated With Right Ventricular Dysfunction and Nitrative Stress in Heart Failure
David J. Kennedy et al.
CIRCULATION-HEART FAILURE (2015)
Indoxyl sulfate induces oxidative stress and hypertrophy in cardiomyocytes by inhibiting the AMPK/UCP2 signaling pathway
Ke Yang et al.
TOXICOLOGY LETTERS (2015)
Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Path physiology to Treatment
Luca Di Lullo et al.
CARDIORENAL MEDICINE (2015)
Klotho and Phosphate Are Modulators of Pathologic Uremic Cardiac Remodeling
Ming Chang Hu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Mitochondrial dysfunction in uremic cardiomyopathy
David Taylor et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
L-Carnitine supplementation for adults with end-stage kidney disease requiring maintenance hemodialysis: a systematic review and meta-analysis
Yizhi Chen et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2014)
Spironolactone Reduces Cardiovascular and Cerebrovascular Morbidity and Mortality in Hemodialysis Patients
Yoshihiro Matsumoto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
The Uremic Toxicity of Indoxyl Sulfate and p-Cresyl Sulfate: A Systematic Review
Raymond Vanholder et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
The Role of Cardiotonic Steroids in the Pathogenesis of Cardiomyopathy in Chronic Kidney Disease
Davor Pavlovic
NEPHRON CLINICAL PRACTICE (2014)
Elevated hepatic 11β-hydroxysteroid dehydrogenase type 1 induces insulin resistance in uremia
Ananda Chapagain et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Regulation of the cardiac sodium pump
W. Fuller et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Cardiac Metabolism in Heart Failure Implications Beyond ATP Production
Torsten Doenst et al.
CIRCULATION RESEARCH (2013)
Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes
Stephen C. Kolwicz et al.
CIRCULATION RESEARCH (2013)
Posttranslational Modifications of GLUT4 Affect Its Subcellular Localization and Translocation
Jessica B. A. Sadler et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Inducible Overexpression of GLUT1 Prevents Mitochondrial Dysfunction and Attenuates Structural Remodeling in Pressure Overload but Does Not Prevent Left Ventricular Dysfunction
Renata O. Pereira et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)
Renal failure and acute myocardial infarction: Clinical characteristics in patients with advanced chronic kidney disease, on dialysis, and without chronic kidney disease. A collaborative project of the United States Renal Data System/National Institutes of Health and the National Registry of Myocardial Infarction
Gautam R. Shroff et al.
AMERICAN HEART JOURNAL (2012)
GLUT4, GLUT1, and GLUT8 are the dominant GLUT transcripts expressed in the murine left ventricle
Lauren Aerni-Flessner et al.
CARDIOVASCULAR DIABETOLOGY (2012)
Value of Carnitine Therapy in Kidney Dialysis Patients and Effects on Cardiac Function from Human and Animal Studies
Rebekah Molyneux et al.
CURRENT DRUG TARGETS (2012)
Targeting myocardial substrate metabolism in heart failure: potential for new therapies
Hossein Ardehali et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Metabolic Syndrome and Insulin Resistance as Risk Factors for Development of Chronic Kidney Disease and Rapid Decline in Renal Function in Elderly
Hui-Teng Cheng et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Regulation of glucose transport by insulin: traffic control of GLUT4
Dara Leto et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Chronic Kidney Disease-Induced Cardiac Fibrosis Is Ameliorated by Reducing Circulating Levels of a Non-Dialysable Uremic Toxin, Indoxyl Sulfate
Suree Lekawanvijit et al.
PLOS ONE (2012)
Uremic cardiomyopathy is characterized by loss of the cardioprotective effects of insulin
David J. Semple et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Glucose metabolism and cardiac hypertrophy
Stephen C. Kolwicz et al.
CARDIOVASCULAR RESEARCH (2011)
Mechanisms of reduced contractility in an animal model of hypertensive heart failure
Marie-Louise Ward et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2011)
Risk factors and metabolic mechanisms in the pathogenesis of uraemic cardiac disease
Sunil Bhandari
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Uremic Cardiomyopathy and Insulin Resistance: A Critical Role for Akt?
David Semple et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)
Endogenous cardiotonic steroids in chronic renal failure
Elena V. Kolmakova et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Endogenous cardiotonic steroids and salt-sensitive hypertension
Olga V. Fedorova et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Renal Ischemia Regulates Marinobufagenin Release in Humans
Jiang Tian et al.
HYPERTENSION (2010)
The Randle cycle revisited: a new head for an old hat
Louis Hue et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Substrate-Enzyme Competition Attenuates Upregulated Anaplerotic Flux Through Malic Enzyme in Hypertrophied Rat Heart and Restores Triacylglyceride Content Attenuating Upregulated Anaplerosis in Hypertrophy
Kayla M. Pound et al.
CIRCULATION RESEARCH (2009)
Metabolic shifts during cardiac hypertrophy
Meera Kaur et al.
CLINICAL LIPIDOLOGY (2009)
What is the mitochondrial permeability transition pore?
Andrew P. Halestrap
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Insulin resistance and altered glucose transporter 4 expression in experimental uremia
Dunja Aksentijevic et al.
KIDNEY INTERNATIONAL (2009)
Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets
A. Y. Bagrov et al.
PHARMACOLOGICAL REVIEWS (2009)
Alterations in mitochondrial function and cytosolic calcium induced by hyperglycemia are restored by mitochondrial transcription factor A in cardiomyocytes
Jorge Suarez et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2008)
Cardiac metabolic compensation to hypertension requires lipoprotein lipase
Haruyo Yamashita et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2008)
Role of diet and fuel overabundance in the development and progression of heart failure
David J. Chess et al.
CARDIOVASCULAR RESEARCH (2008)
Cardiac hypertrophy is enhanced in PPARα-/- mice in response to chronic pressure overload
Pascal J. H. Smeets et al.
CARDIOVASCULAR RESEARCH (2008)
Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats
Songping Han et al.
DIABETES (2008)
Low-carbohydrate/high-fat diet attenuates pressure overload-induced ventricular remodeling and dysfunction
Monika K. Duda et al.
JOURNAL OF CARDIAC FAILURE (2008)
Deleterious effect of altered myocardial fatty acid metabolism in kidney disease
Vasken Dilsizian et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Compensated cardiac hypertrophy is characterised by a decline in palmitate oxidation
Ashwin Akki et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2008)
Chronic kidney disease and its complications
Robert Thomas et al.
PRIMARY CARE (2008)
Hypertrophy and fibrosis in the cardiomyopathy of uremia - Beyond coronary heart disease
Marie-Luise Gross et al.
SEMINARS IN DIALYSIS (2008)
Epidemiology of Chronic Kidney Disease in Heart Failure
Ali Ahmed et al.
Heart Failure Clinics (2008)
Partial nephrectomy as a model for uremic cardiomyopathy in the mouse
David J. Kennedy et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Evidence for increased risk of prediabetes in the uremic patient
Walid Shehab Eldin et al.
NEPHRON CLINICAL PRACTICE (2008)
Long-term effects of increased glucose entry on mouse hearts during normal aging and ischemic stress
Ivan Luptak et al.
CIRCULATION (2007)
Alterations in levels of O-linked N-acetylglucosamine modified proteins in the uraemic heart
David A. Ashford et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Recruitment of compensatory pathways to sustain oxidative flux with reduced carnitine palmitoyltransferase I activity characterizes inefficiency in energy metabolism in hypertrophied hearts
Natalia Sorokina et al.
CIRCULATION (2007)
Mechanisms of disease - The failing heart - An engine out of fuel
Stefan Neubauer
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Myocardial function, energy provision, and carnitine deficiency in experimental uremia
Veena Reddy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Advances in carnitine in chronic uremia
Gianfranco Guarnieri et al.
JOURNAL OF RENAL NUTRITION (2007)
Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit
Sharon L. Hale et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2006)
Diastolic dysfunction and abnormality of the Na+/Ca2+ exchanger in single uremic cardiac myocytes
AC McMahon et al.
KIDNEY INTERNATIONAL (2006)
Mechanical stretch-induced hypertrophy of neonatal rat ventricular myocytes is mediated by beta(1)-integrin-microtubule signaling pathways
YT Xi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2006)
Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFκB activation in vivo
TZ Ha et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Glucose transporter 4: cycling, compartments and controversies - Third in the cycles review series
CB Dugani et al.
EMBO REPORTS (2005)
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure
I Shiojima et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury
T Nagoshi et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Clinical epidemiology of cardiovascular disease in chronic kidney disease
K Kundhal et al.
NEPHRON CLINICAL PRACTICE (2005)
A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure
Y Komiyama et al.
CLINICAL BIOCHEMISTRY (2005)
Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes
I Shiraishi et al.
CIRCULATION RESEARCH (2004)
Effects of chronic renal failure on caveolin-1, guanylate cyclase and AKT protein expression
RK Sindhu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2004)
Mechanisms for increased glycolysis in the hypertrophied rat heart
L Nascimben et al.
HYPERTENSION (2004)
Calcium-calcineurin signaling in the regulation of cardiac hypertrophy
BJ Wilkins et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Phosphoinositide 3-kinase(p110α) plays a critical role for the induction of physiological, but not pathological, cardiac hypertrophy
JR McMullen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Phosphotransfer networks and cellular energetics
PP Dzeja et al.
JOURNAL OF EXPERIMENTAL BIOLOGY (2003)
Cardiomyocyte loss in experimental renal failure:: Prevention by ramipril
K Amann et al.
KIDNEY INTERNATIONAL (2003)
Effect of chronic renal failure on cardiac contractile function, calcium cycling, and gene expression of proteins important for calcium homeostasis in the rat
D Kennedy et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2003)
Cardiac hypertrophy: The good, the bad and the ugly
N Frey et al.
ANNUAL REVIEW OF PHYSIOLOGY (2003)
The cardiac ryanodine receptor (calcium release channel): Emerging role in heart failure and arrhythmia pathogenesis
M Scoote et al.
CARDIOVASCULAR RESEARCH (2002)
Cardiac-specific overexpression of GLUT1 prevents the development of heart failure attributable to pressure overload in mice
RL Liao et al.
CIRCULATION (2002)
Metabolic plasticity and the promotion of cardiac protection in ischemia and ischemic preconditioning
LH Opie et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2002)
Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease
K Shinohara et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2002)
Prolonged calcium transients and myocardial remodelling in early experimental uraemia
AC McMahon et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Metabolic gene expression in fetal and failing human heart
P Razeghi et al.
CIRCULATION (2001)
Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function
SM Periyasamy et al.
KIDNEY INTERNATIONAL (2001)
Akt1/PKBα is required for normal growth but dispensable for maintenance of glucose homeostasis in mice
H Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy
R Tian et al.
CIRCULATION (2001)
Deactivation of peroxisome proliferator-activated receptor-α during cardiac hypertrophic growth
PM Barger et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
L-type calcium current of isolated rat cardiac myocytes in experimental uraemia
P Donohoe et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Glut-1 expression and its response to hypoglycemia in the embryonic mouse heart
IW Smoak et al.
ANATOMY AND EMBRYOLOGY (2000)
分享论文
